ON

Ola Nilsson

Head of Neoantigen Development at NEOGAP Therapeutics AB

Ola Nilsson has an extensive work experience history in the biotechnology industry. Ola currently serves as the Head of Neoantigen Development at NEOGAP Therapeutics AB, where they lead a team focused on the research, development, and production of Neoantigens. Ola has been involved in the scientific development of the EpiTCer beads technology used by the company to treat cancer.

Before joining NEOGAP Therapeutics AB, Ola worked as the Bioengineering Manager at the same company, where they participated in establishing a production process for manufacturing raw materials for personalized advanced therapy medicinal products.

Prior to their time at NEOGAP Therapeutics AB, Ola worked at TCER AB as a Principal Research Scientist in biotechnology and quality assurance. In this role, they designed, produced, and ensured the quality of recombinant biologicals, developing and implementing methods for clinical trials.

Ola's career began at Stockholm University, where they worked as a Postdoctoral Research Fellow in the group of Professor Gunnar von Heijne. Ola'sresearch focused on co-translational protein folding and characterizing nascent chain folding at the ribosomal exit tunnel.

Ola also holds a PhD from Karolinska Institutet, where they conducted research as a PhD student.

Overall, Ola Nilsson's work experience spans various roles in biotechnology research, development, and production, with a particular emphasis on Neoantigen development and personalized advanced therapy medicinal products.

Ola Nilsson's education history includes a Doctor of Philosophy (Ph.D.) degree in Medicin, which was obtained from Karolinska Institutet between 2008 and 2012. Prior to that, from 2003 to 2007, Ola Nilsson obtained a Master of Science (M.Sc.) degree in Biomedicin, also from Karolinska Institutet. In addition to these academic achievements, Ola Nilsson has a certification in NEOGAP LEADERSHIP PROGRAM from Chefakademin, obtained in February 2023. In 2005, Ola Nilsson had a brief period at Leiden University Medical Center, but it is not specified whether a degree or specific field of study was obtained during that time.

Links

Previous companies

Karolinska Institutet logo
Stockholm University logo

Timeline

  • Head of Neoantigen Development

    April, 2022 - present

  • Bioengineering Manager

    March, 2020

A panel showing how The Org can help with contacting the right person.